Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.98

+1.1%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (7658)	1/6/2003 12:56:49 PM
From: Jibacoa	Read Replies (1) of 52153

Ted Griffith at CBS MarketWatch also had some negative comments about the prospects from the H&Q conference. cbs.marketwatch.com He has positive comments about AMGN that in December said it expects its 2003 profit,( excluding acquisition-related charges <g>) to be up 31%, driven by strong sales of the new anti-anemia and anti-infection drugs.The company is having a full page color advertisement in the Miami Herald today about the FDA approval of its RI facility to manufacture EMBREL. RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next